High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias von Waterfall, Joshua J, Arons, Evgeny, Walker, Robert L, Pineda, Marbin, Roth, Laura, Killian, J Keith, Abaan, Ogan D, Davis, Sean R, Kreitman, Robert J, Meltzer, Paul S

Volltext

Expression of the muscle-associated gene MYF6 in hairy cell leukemia von Arons, Evgeny, Zhou, Hong, Sokolsky, Mark, Gorelik, Daniel, Potocka, Katherine, Davies, Sarah, Fykes, Erin, Still, Katherine, Edelman, Daniel C, Wang, Yonghong, Meltzer, Paul S, Raffeld, Mark, Wiestner, Adrian, Xi, Liqiang, Wang, Hao-Wei, Stetler-Stevenson, Maryalice, Yuan, Constance, Kreitman, Robert J

Volltext

In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees von Pemov, Alexander, Pathak, Anand, Jones, Samantha J., Dewan, Ramita, Merberg, Jessica, Karra, Sirisha, Kim, Jung, Arons, Evgeny, Ravichandran, Sarangan, Luke, Brian T., Suman, Shalabh, Yeager, Meredith, Dyer, Martin J. S., Lynch, Henry T., Greene, Mark H., Caporaso, Neil E., Kreitman, Robert J., Goldin, Lynn R., Spinelli, John J., Brooks-Wilson, Angela, McMaster, Mary L., Stewart, Douglas R.

Volltext

P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL von Vit, Filippo, Bittolo, Tamara, Papotti, Robel, Pozzo, Federico, Zucchetto, Antonella, Tissino, Erika, Zaina, Eva, Catarossi, Ilaria, Laureana, Roberta, Olivieri, Jacopo, Bulian, Pietro, Levato, Luciano, D’arena, Giovanni, Armiento, Daniele, Zamò, Alberto, Leich, Ellen, Rosenwald, Andreas, Arons, Evgeny, J. Kreitman, Robert, Gentile, Massimo, Laurenti, Luca, Zaja, Francesco, Tafuri, Agostino, Chiarenza, Annalisa, Ilaria DEL Principe, Maria, Gattei, Valter, Bomben, Riccardo

Volltext

Impact of telomere length on survival in classic and variant hairy cell leukemia von Arons, Evgeny, Zhou, Hong, Edelman, Daniel C, Gomez, Allison, Steinberg, Seth M, Petersen, David, Wang, Yonghong, Meltzer, Paul S, Kreitman, Robert J

Volltext

Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues von Kreitman, Robert J., Arons, Evgeny

Volltext

Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation von Xi, Liqiang, Arons, Evgeny, Navarro, Winnifred, Calvo, Katherine R., Stetler-Stevenson, Maryalice, Raffeld, Mark, Kreitman, Robert J.

Volltext

Minimal Residual Disease in Hairy Cell Leukemia Patients Assessed by Clone-Specific Polymerase Chain Reaction von ARONS, Evgeny, MARGULIES, Inger, SORBARA, Lynn, RAFFELD, Mark, STETLER-STEVENSON, Maryalice, PASTAN, Ira, KREITMAN, Robert J

Volltext

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia von Chihara, Dai, Arons, Evgeny, Stetler-Stevenson, Maryalice, Yuan, Constance M, Wang, Hao-Wei, Zhou, Hong, Raffeld, Mark, Xi, Liqiang, Steinberg, Seth M, Feurtado, Julie, James, Lacey, Wilson, Wyndham, Braylan, Raul C, Calvo, Katherine R, Maric, Irina, Dulau-Florea, Alina, Kreitman, Robert J

Volltext

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy von Arons, Evgeny, Suntum, Tara, Stetler-Stevenson, Maryalice, Kreitman, Robert J.

Volltext

Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation–positive hairy cell leukemia von Kreitman, Robert J., Moreau, Philippe, Ravandi, Farhad, Hutchings, Martin, Gazzah, Anas, Michallet, Anne-Sophie, Wainberg, Zev A., Stein, Alexander, Dietrich, Sascha, de Jonge, Maja J. A., Willenbacher, Wolfgang, De Grève, Jacques, Arons, Evgeny, Ilankumaran, Palanichamy, Burgess, Paul, Gasal, Eduard, Subbiah, Vivek

Volltext

Update on hairy cell leukemia von Kreitman, Robert J, Arons, Evgeny

Volltext

The bruton tyrosine kinase inhibitor ibrutinib (PCI‐32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach von Sivina, Mariela, Kreitman, Robert J., Arons, Evgeny, Ravandi, Farhad, Burger, Jan A.

Volltext

Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia von BUROTTO, Mauricio, STETLER-STEVENSON, Maryalice, ARONS, Evgeny, HONG ZHOU, WILSON, Wyndham, KREITMAN, Robert J

Volltext

An Immunogenetic Imprint of Ongoing Antigen Interactions in Hairy Cell Leukemia Expressing IGHV4-34 Receptors von Sofou, Electra, Karypidou, Maria, Zaragoza-Infante, Laura, Pechlivanis, Nikolaos, Psomopoulos, Fotis, Georgiou, Elisavet, Arons, Evgeny, Kreitman, Robert J., Chatzidimitriou, Anastasia, Stamatopoulos, Kostas

Volltext

Abstract 4595: Moxetumomab pasudotox spares CD4 and CD8 lymphocytes in multiply relapsed hairy cell leukemia patients, while prospective trials of first, second, and later lines of... von Kreitman, Robert J., Stetler-Stevenson, Maryalice, Arons, Evgeny, Pastan, Ira

Volltext

Characterization of B‐cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS‐CoV‐2 infection von Arons, Evgeny, Henry, Kiersten, Haas, Christopher, Gould, Mory, Tsintolas, Jack, Mauter, Jack, Zhou, Hong, Burbelo, Peter D., Cohen, Jeffrey I., Kreitman, Robert J.

Volltext

Hairy cell leukemia variant and WHO classification correspondence Re: 5$^{th}$ edition WHO classification haematolymphoid tumors: lymphoid neoplasms von Grever, Michael, Andritsos, Leslie, Anghelina, Mirela, Arons, Evgeny, Banerji, Versha, Barrientos, Jacqueline, Bhat, Seema A, Blachly, James, Broccoli, Alessandro, Call, Timothy, Dearden, Claire, Dietrich, Sascha, Else, Monica, Epperla, Narendranath, Fagarasanu, Andrei, Falini, Brunangelo, Forconi, Francesco, Gozzetti, Alessandro, Hampel, Paul, Hermel, David J, Iyengar, Sunil, Johnston, James B, Juliusson, Gunnar, Kreitman, Robert J, Lauria, Francesco, Lozanski, Gerard, Oakes, Christopher C, Parikh, Sameer A, Park, Jae, Zenz, Thorsten

Volltext

Extended Follow up of a Phase 2 Study of Ibrutinib in Hairy Cell Leukemia von Rogers, Kerry A., McLaughlin, Eric, Wei, Lai, Anghelina, Mirela Iulia, Ali, Mir Khader, Andritsos, Leslie A., Arons, Evgeny, Blachly, James S., Call, Timothy G., Ivy, S. Percy, James-Echenique, Lacey, Jones, Jeffrey A., Kreitman, Robert J., Lozanski, Gerard, Ravandi, Farhad, Schiffer, Charles A., Carson, William E., Grever, Michael R.

Volltext

Phase 1 trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox combined with rituximab for relapsed/refractory hairy cell leukemia von Kreitman, Robert J., Stetler-Stevenson, Maryalice, Yuan, Constance, Wang, Hao-Wei, Zhou, Hong, Raffeld, Mark, Xi, Liqiang, Arons, Evgeny, Feurtado, Julie, James-Echenique, Lacey, Braylan, Raul, Calvo, Katherine R., Maric, Irina, Dulau, Alina, Pastan, Ira

Volltext